Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cline Scientific Appoints Four New Scientific Advisors

Gothenburg, Sweden, February 19, 2020:  Cline announces that the Scientific Advisors from Liv Diagnostics and Associate Professor Reza Mobini now are a part of Cline Scientific’s advisory board. Their experience and credentials will provide ongoing support for Cline’s strategic direction to move the cancer diagnostic project forward.“This product will provide unique diagnostic information and have the potential to become a very valuable tool to help prevent cancer from spreading. High precision diagnostics of metastasis is a crucial part of successful cancer treatment. This technology

Ahlstrom-Munksjö launches sustainable line of confectionary papers

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE February 19, 2020 at 10:00 AM EET Ahlstrom-Munksjö has launched its enhanced line of sustainable and safe specialty papers geared towards the confectionary market, known as Delicitera® Confectionary Papers. With its impactful shelf presence and renewable properties, Ahlstrom-Munksjö’s Delicitera® Confectionery Papers drive food packaging differentiation in today’s rapidly evolving marketplace. Customized solutions are created for customers by combining an array of visual, functional and sustainable benefits. “Our confectionary papers are made of

Nordax Bank AB (publ) – Early redemption of subordinated Tier 2 notes

Press release 19 February 2020 Nordax Bank AB (publ) (the “Issuer”) informs that it intends to voluntarily redeem the SEK 250,000,000 floating rate subordinated callable Tier 2 notes with ISIN SE0006758249 (the “Notes”) on the first call date in accordance with the terms and conditions dated 12 March 2015. All outstanding Notes will be redeemed in full at their nominal amount, together with accrued but unpaid interest. In connection with the redemption, the Notes will be delisted from Nasdaq Stockholm. The redemption date is expected to be 18 March 2020. A notice of early redemption

Glaston’s comprehensive product portfolio results in follow-up order from customer in North America

Glaston Corporation    Press release   19 February 2020Glaston Group has closed a deal for a FC Series™ flat glass tempering line with a leading glass fabricator in North America. The order has been booked in Glaston’s Q1/2020 order book. The line is due to be delivered to the customer in Q4/2020. The deal is a follow-up to orders placed in 2019 for advanced TPS® insulating glass lines and state of the art ProL lamination zone ovens for lamination. The orders reinforce how Glaston’s extensive product portfolio offers great cross-selling opportunities which benefit our customers by

Hine Group turns to IFS to unify and expand its business globally

Leading hydraulics solution provider to the renewable energy sector to deploy comprehensive ERP suite from IFS at Spanish headquarters and across subsidiaries in USA, China, India, and Brazil London, February 19, 2020 – IFS , the global enterprise applications company, announces that Hine Group , the global supplier of hydraulic solutions and cooling systems for industrial and renewable energy companies, has selected IFS Applications™  to ensure improved operational efficiency and

iLOQ continues co-operation with Formula One world champion Kimi Räikkönen

iLOQ – the leading innovator of self-powered digital and mobile access management systems – is continuing its cooperation with Formula One World Champion Kimi Räikkönen also for the 2020 season. “It has been a great publicity coup and a real pleasure to work with such a world-renowned figure as Kimi Räikkönen. Together, we created some fantastic experiences in 2019 which were extremely well received by our customers and partners. With the 2020 Formula 1 season due to start soon, and with events like the Expo 2020 being held in Dubai, Kimi’s strong reputation and high-profile will

David Gardner joins Embracer Group’s Board of Directors

The Extraordinary General Meeting of Embracer Group AB (publ) held today, has elected David Gardner as a new board member as of 1 April 2020. David Gardner has a solid industry background and his professional experience includes entrepreneurial and senior management positions in both Electronic Arts and Atari S.A.”Over the past few years, I´ve watched Embracer Group making a positive impact in the games market and I’m really happy to bring my experience to the company as they continue and accelerate their plans“, says David Gardner. He joins the board as of 1 April 2020. All current

Fight, flight or flow? Our Neolithic brains appreciate working spaces tailored to our needs

YIT Corporation News 19 February 2020Many companies already know that they need to pay attention to physical ergonomics, but perfecting brain ergonomics is still very much in the works. Tailor-made workspaces help keep our capital assets in prime condition and exhaustion at bay. An organisation can make the most of new premises if it is also prepared to fine-tune its working practices and culture. The concerns of a Stone Age human were very different from those of a modern-day office worker. A contemporary specialist does not normally need to worry about getting eaten by a predator! On

NeuroVive Pharmaceutical AB Year End Report January - December 2019

Important events in 2019 KL1333 · NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study · NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study · NeuroVive completes recruitment of healthy volunteers in the second part of its ongoing KL1333 clinical Phase Ia/b study NV354 · NeuroVive initiates NV354 preclinical safety studies and scales up compound production NeuroSTAT · NeuroVive’s IND for clinical development of NeuroSTAT approved by FDA · NeuroSTAT receives Fast Track designation from the US Food and

Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)

The shareholders of NeuroVive Pharmaceutical AB (publ), 556595-6538, are hereby convened to the Extraordinary General Meeting, held at 3 pm on Tuesday 17 March 2020 at Medicon Village, Scheelevägen 2, in Lund, Sweden.Entitlement to participate and notification Shareholders that wish to participate at the Extraordinary General Meeting should: · be included in the share register maintained by Euroclear Sweden AB on Wednesday 11 March 2020, and · notify the company by email to anmalan@neurovive.com or, in writing to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevägen 2, 223

Long-term contract with Premier Oil UK

Solstad Offshore ASA is pleased to announce that Premier Oil UK Limited (“Premier Oil”) has contracted PSV Normand Flipper (UT745E, 2003 built) for four wells firm plus options commencing between May and June 2020. The contract is expected to last around 400 days supporting the jackup drilling rig Valaris JU-123 at Premier Oil’s Tolmount location in the southern North Sea. Skudeneshavn, February 19th, 2020 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Solstad Offshore ASAwww.solstad.com

Large UK healthcare provider prolongs its radiology imaging contract with Sectra and consolidates its systems

Linköping, Sweden – February 19, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has received an order for its radiology imaging solution from the British SWASH consortium of NHS Trusts (Salisbury, Wight, and South Hampshire Domain Trusts). The consortium has prolonged its radiology imaging contract with Sectra and will consolidate its four existing solutions into one. This will allow for efficient access and collaboration around patient imaging and reduce complexity, while also improving enterprise-wide access.“We have high-

Biohit Group Financial Statement Release 2019

Biohit Oyj Financial Statement Release  SUMMARY January-December 2019 · Net sales EUR 10.1 million (EUR 9.9 million) · Net sales grew by 1.2% compared to 2018 · Operative EBITDA EUR +0.6 million (EUR -0.1 million)* · Cash at the end of the period EUR 1.3 million (EUR 1.4 million) · Net sales from international operations 96.0% (95.6%) of total net sales · Equity ratio 83.9% (89.2%)** * Biohit Group implemented the IFRS 16 Leases -standard effective from 1 January 2019. This impacted on Operative EBITDA +0.2 million euros in 2019 due to reason that comparative

Notice to Annual General Meeting in Atrium Ljungberg AB (publ)

The shareholders of Atrium Ljungberg AB (publ) are hereby invited to the Annual General Meeting to be held on Wednesday 25 March 2020 at 5.00 p.m. at Filmstaden, Marcusplatsen 19 in Sickla, NackaNotice of Attendance Shareholders who wish to attend the General Meeting shall: i. have entered into the share register kept by Euroclear Sweden AB on Thursday 19 March 2020; and ii. give notice of his or her intention to participate at the General Meeting no later than Friday 20 March 2020. Notice of attendance at the General Meeting shall be made via the Company’s website www.al.se, by e‐

SBB presents Vision 2030: 100 percent climate neutral

Sustainability is a natural part of Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB")’s business model and SBB strives to be the most sustainable property company in the world. In order to achieve this, SBB has launched Vision 2030 which sets out clear goals.OVERALL OBJECTIVES · Govern the company’s operations in line with the UN global sustainable development goals: (5), (7), (8), (11), (13), (15) · 100 percent climate neutral by 2030 · Minimizing the risks to the company’s assets by continuously reviewing the climate risks in the property portfolio · Regularly improving,

NeuroVive proposes a rights issue of MSEK 74 and accelerates the clinical development of KL1333

Lund, Sweden, 19 February 2020, NeuroVive Pharmaceutical AB (Nasdaq Stockholm) today announced that the Board of Directors of NeuroVive Pharmaceutical AB (publ) (“NeuroVive” or the “Company”) has resolved, subject to approval by the Extraordinary General Meeting, on a new share issue with preferential rights for the Company’s existing shareholders (the “Rights issue”) in order to ensure that the Company has financial resources for its prioritized primary mitochondrial disease  (PMD) programs, primarily the continued clinical development of KL1333.The Board's resolution on the Rights issue

Sports without borders will strengthen children’s self-confidence in Tyresö

Cooperation is now starting among Sports without borders, Wallenstam and Tyresö Municipality in order to strengthen children’s self-confidence and reduce social exclusion in Tyresö. The methodology is about letting sports become a way into the community for children and young people. During 2019, Sports without borders worked with 18,900 children at 90 schools in six municipalities around the country. Now the activities have also started in Tyresö, where Wallenstam has about 240 rental apartments and a further 221 in production.“There are many children in Sweden who do not see opportunities

Studsvik granted patents for Waste Treatment Technology

Studsvik has been granted patents for Treatment of Organic Radioactive Waste and Contaminated Sludge Removal. These methods are employed in Studsvik’s Fluidized Bed Steam Reforming (FBSR) and Freeze-Tec technology commercial offerings. (U.S. Patent Application No. 16/227,848; Divisional of U.S. Non-Provisional Patent Application No. 14/609,738; APPARATUS AND METHODS FOR TREATMENT OF RADIOACTIVE ORGANIC WASTE)(European Patent Application No. 11775381.4; European Patent No. EP2564395NWB - METHOD AND DEVICE FOR SLUDGE HANDLING)Studsvik’s FBSR technology provides a superior treatment of high,

Year-end report January – December 2019

January–December 2019  • Rental income increased 14 percent driven primarily by a growing property portfolio. The increase for the comparable portfolio was 3.5 percent. • Net operating income increased 15 percent, of which 3 percent in the comparable portfolio. • The surplus ratio was strengthened by almost half a percentage point. Operating expenses were charged with non-recurring costs for the current quarter while the corresponding quarter in the preceding year reported non-recurring income. • Profit from property management increased 12 percent, primarily driven by a larger

OPTIONS GRANTED

Oslo, Norway (19 February 2020) — Based on the power of attorney granted at the annual general meeting of NattoPharma ASA ("NattoPharma" or "Company") on May 29th, 2019, and the option program related to defined operational objectives approved by the Board of Directors in 2019, the Board of Directors of NattoPharma has in board proceedings February 18th, 2020 granted a total of 155 000 options to executive management, other employees and strategic partners. Options are granted based on performance against defined criteria and metrics. The following persons on the executive management

Invitation to Embracer Group’s presentation and call about acquisition of Saber Interactive

Embracer Group hereby invites you to a presentation for investors and media on the occasion of this morning press release head-lined “Embracer Group acquires Saber Interactive – initial consideration USD 150 million”. The presentation will be held in conjuction with the previously announced presentation of Embracer Group’s Q3-report, today at 09:00 (CET).The presentation will be held in English by CEO Lars Wingefors and afterwards questions are invited. Matthew Karch, CEO and co-founder, Andrey Iones, COO and co-founder and Tim Willits, Chief Creative Officer of Saber Interactive, will all

BONESUPPORT HOLDING AB (publ) – Full Year Report 2019 – invitation to conference call and webcast

Lund, Sweden, 08.00 am CET, 19 February 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, will publish its Full Year Report 2019, on the 26 February at 08.00 am CET. The Company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by Emil Billbäck, CEO and Håkan Johansson, CFO who will present the results and answer questions. The presentation will be held in English. The dial-in numbers for the conference call are: UK: +44 333 300 92 60 SE: +46 8 505 583 50

NOTICE OF EXTRA GENERAL MEETING IN EMBRACER GROUP AB

The shareholders of Embracer Group AB, reg. no. 556582-6558, (the "Company") are hereby invited to the extra general meeting on Wednesday 11 March 2020 at 10.00 am CET at Baker McKenzie's premises at Vasagatan 7 in Stockholm. The doors to the meeting will open at 09.45 am CET.Right to attend and notification Shareholders who wish to attend the extra general meeting must: i. on the record date, which is Thursday 5 March 2020, be registered in the share register maintained by Euroclear Sweden AB; and ii. notify the company of their participation and any assistants (no more than two)

Director/PDMR Shareholding

19 February 2020 07:00 GMT     TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIESDisclosure under Article 19 of the EU Market Abuse Regulation   AstraZeneca PLC (the Company) announces that, on 17 February 2020, it was notified by Michel Demaré, a Non-Executive Director of the Company, that, on 17 February 2020, Mr Demaré purchased 700 Ordinary Shares of $0.25 each in the Company (Shares) at a price of £73.13 per Share.The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.   1

There are no items matching the current filter
There are no more items matching the current filter
Back to top